Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin vs Rivaroxaban for Thromboprophylaxis in Newly Diagnosed Multiple Myeloma
NCT07907211Phase 4Recruiting
- Start
- Feb 2024
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in venous thromboembolism (VTE). Started Feb 2024; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT07907211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07907211.